CNTX Context Therapeutics
- 1.3200
- -0.0900-6.38%
Context Therapeutics News
Context Therapeutics | 8-K: Current report
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Minai-Azary Jennifer Lynn
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Levit Alex C.
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lehr Martin A.
Context Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Context Therapeutics | 10-K: Annual report
Context Therapeutics | 8-K: Current report
Context Therapeutics | 8-K: Current report
Context Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Affinity Healthcare Fund, LP (EIN(2.06%),Affinity Asset Advisors, LLC (EIN(2.06%)
Context Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Martin Lehr(8.8%),Martin Lehr 2000 Trust(5.1%), etc.
Context Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Opaleye Management Inc.(5.14%)
Context Therapeutics: Q3 2023 Earnings Report
Context Therapeutics | 8-K: Current report
Context Therapeutics | 10-Q: Q2 2023 Earnings Report
Context Therapeutics | 8-K: Current report
Context Therapeutics | 8-K: Current report
Context Therapeutics | 8-K: Current report
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kantoff Philip W.
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director West Linda
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Stacey Jennifer Evans
Analysis
Price Target
No Data
